miR-206 as a prognostic and sensitivity biomarker for platinum chemotherapy in epithelial ovarian cancer

alexandrossfakianakis shared this article with you from Inoreader miR-206 as a prognostic and sensitivity biomarker for platinum chemotherapy in epithelial ovarian cancer Via Cancer Cell International - Latest Articles Drug resistance is a major obstacle to successful chemotherapy for epithelial ovarian cancer (EOC). We found a subset of miRNAs associated with the response to first-line platinum-based chemotherapy in EOC by ... View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.